Home/Filings/4/0000899243-22-007009
4//SEC Filing

Sathyanarayanan Sriram 4

Accession 0000899243-22-007009

CIK 0001659352other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:05 PM ET

Size

8.1 KB

Accession

0000899243-22-007009

Insider Transaction Report

Form 4
Period: 2022-02-16
Sathyanarayanan Sriram
Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units

    2022-02-16+29,40029,400 total
    Common Stock (29,400 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-02-16+19,60019,600 total
    Exercise: $5.21Exp: 2032-02-15Common Stock (19,600 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]On February 16, 2022, the reporting person was granted 29,400 restricted stock units, vesting in four equal installments every six months beginning on the six months anniversary of the grant date.

Issuer

Codiak BioSciences, Inc.

CIK 0001659352

Entity typeother

Related Parties

1
  • filerCIK 0001867898

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:05 PM ET
Size
8.1 KB